Bioperfectus SSNP-2000B Nucleic Acid Extraction System Wins iF Design Award 2022

Company news
2022-04-12

 

Shanghai, China, April 12, 2022—Today, Jiangsu Bioperfectus Technologies Co., Ltd. (Bioperfectus) is pleased to announce that our SSNP-2000B Nucleic Acid Extraction System has won the iF DESIGN AWARD 2022 in recognition of its unique structure and innovative design.

 

iF DESIGN AWARD is one of the most prestigious design awards worldwide. Each iF Design Award Final Jury entry is assessed by several jurors in five aspects criteria, including Idea, Form, Function, Differentiation, and Impact. Bioperfectus SSNP-2000B Nucleic Acid Extraction System stands out among over 11,000 entries from 57 countries with its simple, minimalist, unique, and eco-friendly design concept, which combines multi-function in its high-quality product specifications.

 

SSNP-2000B is an industry innovative automatic nucleic acid extractor that is compact and lightweight and perfectly fits the biosafety cabinet. It adopts the magnetic bead method to extract and purify nucleic acid from various clinical standard samples. A built-in HEPA filter, which can create an air circulation inside combined with a UV lamp, can dramatically avoid contamination among samples and keep the accuracy of results. In addition, the extraction process for COVID-19, HPV, STD, and vector-borne samples do not require additional reagents, and the fully automated operation reduces labor costs. It can maximize the efficiency of the assay.

 

“It is an honor to earn iF design recognition upon the celebration of Bioperfectus 12th Anniversary,” said Deputy General Manager of Bioperfectus International Sales & Marketing Division, “Our highly talented and experienced engineering and R&D teams, focused on listening carefully to laboratory technicians and healthcare workers throughout the entire research and development process. They responded to those needs in designing each aspect of the Bioperfectus System. We’re excited to be bringing this new option to our partners and end-users.”

 

Looking ahead, Bioperfectus will continue its commitment to offering high-quality molecular diagnostic laboratory solutions and services to our customers around the globe.

 

About Bioperfectus
Bioperfectus, a public listed company on Shanghai Stock Exchange (SSE:688399), has been one of the leading molecular diagnostic solution providers specializing in infectious diseases ever since 2010. With headquarters located in Jiangsu, subsidiaries in Shanghai, Beijing, Xi'an, Taizhou, Hainan, and Yinchuan. Bioperfectus is pioneering in the molecular diagnostics market with our products ranging from real-time PCR kits, nucleic acid extraction systems, rapid tests, and automation laboratory devices. Young and passionate, Bioperfectus people are working steadily and firmly to achieve our dream to create a healthier future for our next generations. For more information, please click here.

About the iF Design Award
Since 1954, the iF DESIGN AWARD has been recognized as an arbiter of quality for excellent design. The iF Design brand is renowned worldwide for outstanding design services, and the iF DESIGN AWARD is one of the most important design prizes in the world. It honors design achievements in all disciplines: product, packaging, communication and service design, architecture and interior architecture as well as professional concept, user experience (UX), and user interface (UI). All award-winning entries are featured on www.ifdesign.com and published in the iF Design App.  For more information, please click here.

MOST READ

Emergency Release of Bioperfectus Monkeypox Virus Real Time PCR Kit

The recent ongoing monkeypox virus cases outbreak in nonendemic countries caused a series of concerns in public health. As a molecular diagnostic supplier, we are launching Monekypox Virus Real Time PCR Kit as a detection tool to combat the potential spread among people.

2022-05-23

Four Different Dengue Serotypes that Worth Your Attention

Dengue is caused by infection with dengue virus (DENV), a member of the genus Flavivirus, family Flaviviridae.

2022-04-08

Bioperfectus Emergency Response to the Unknown Hepatitis in Children

On 15 April 2022, the World Health Organization (WHO) published an alert on severe acute hepatitis cases of unknown origin in children in the United Kingdom. Since then, there have been continuing additional reports of cases.

2022-05-07